Variant report
Variant | esv3343242 |
---|---|
Chromosome Location | chr5:30298795-30302593 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112713582 | chr5:30299045-30299046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs6883071 | chr5:30299046-30299047 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs4492127 | chr5:30299100-30299101 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs535569264 | chr5:30299145-30299146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547864795 | chr5:30301807-30301808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114701866 | chr5:30301823-30301824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531685851 | chr5:30301828-30301829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs372932343 | chr5:30301832-30301833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551858770 | chr5:30301861-30301862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530101955 | chr5:30301882-30301883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527933591 | chr5:30301972-30301973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548086681 | chr5:30302028-30302029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10071127 | chr5:30302035-30302036 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs536958817 | chr5:30302058-30302059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs113745078 | chr5:30302077-30302078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184807377 | chr5:30302104-30302105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568838443 | chr5:30302121-30302122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537501970 | chr5:30302122-30302123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557874377 | chr5:30302160-30302161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs577760441 | chr5:30302169-30302170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs189661288 | chr5:30302201-30302202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11743556 | chr5:30302202-30302203 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs553634854 | chr5:30302217-30302218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573565279 | chr5:30302221-30302222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs139938870 | chr5:30302259-30302260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs576226014 | chr5:30302284-30302285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562695008 | chr5:30302311-30302312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs116413102 | chr5:30302369-30302370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs545164080 | chr5:30302382-30302383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545299270 | chr5:30302385-30302386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565404926 | chr5:30302397-30302398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141329056 | chr5:30302412-30302413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs150803895 | chr5:30302419-30302420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539319855 | chr5:30302440-30302441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374255417 | chr5:30302466-30302467 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530370294 | chr5:30302509-30302510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs181054385 | chr5:30302571-30302572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:30299000-30299200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr5:30301800-30310200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |